- 353T. doi:10.1038/334353a0. PMID 3393226. S2CID 4263472.
Leevers SJ,
Vanhaesebroeck B,
Waterfield MD (April 1999). "Signalling
through phosphoinositide...
- page". IUPHAR/BPS
Guide to Pharmacology.
Retrieved 21
September 2023.
Vanhaesebroeck B,
Perry MW,
Brown JR, André F,
Okkenhaug K (October 2021). "PI3K inhibitors...
-
Lorraine Symington Sarah Tabrizi Patrick Unwin Mihaela van der
Schaar Bart
Vanhaesebroeck Glynn Winskel William Wisden Xiaodong Zhang Kwame Anthony Appiah Anthony...
- 029. ISSN 1097-4172. PMC 5726441. PMID 28802037. Madsen,
Ralitsa R.;
Vanhaesebroeck, Bart; Semple,
Robert K. (2018-09-06). "Cancer-****ociated PIK3CA Mutations...
- Science. 116 (Pt 15): 3037–3040. doi:10.1242/jcs.00609. PMID 12829733.
Vanhaesebroeck B,
Waterfield MD (November 1999). "Signaling by
distinct classes of...
- (2010-01-01). "Oncogenic
mutations of PIK3CA in
human cancers". In
Rommel C,
Vanhaesebroeck B, Vogt PK (eds.).
Phosphoinositide 3-kinase in
Health and Disease....
- for
recurrent glioblastoma reported not
meeting its
primary endpoint.
Vanhaesebroeck B,
Leevers SJ,
Ahmadi K,
Timms J,
Katso R,
Driscoll PC, et al. (2001)...
- for
services to the
biosciences in the 2023
Birthday Honours. Bart
Vanhaesebroeck;
Melanie J. Welham; Kei Kotani; et al. (29
April 1997). "p110δ, a novel...
-
Center for
Biotechnology Information, U.S.
National Library of Medicine.
Vanhaesebroeck B,
Welham MJ,
Kotani K,
Stein R,
Warne PH,
Zvelebil MJ, et al. (April...
- 2) (2): 395–405. doi:10.1042/bj2880395. PMC 1132024. PMID 1334406.
Vanhaesebroeck B,
Welham MJ,
Kotani K,
Stein R,
Warne PH,
Zvelebil MJ, et al. (April...
